摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

异丙烯基硼酸 | 14559-87-6

中文名称
异丙烯基硼酸
中文别名
2-丙烯硼酸
英文名称
isopropenylboronic acid
英文别名
prop-1-en-2-ylboronic acid
异丙烯基硼酸化学式
CAS
14559-87-6
化学式
C3H7BO2
mdl
MFCD02179500
分子量
85.8984
InChiKey
WCONKKYQBKPMNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    104℃
  • 沸点:
    78-80℃ (18 Torr)
  • 密度:
    0.955±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    0.32
  • 重原子数:
    6
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P310,P330,P332+P313,P362,P403+P233,P405,P501
  • 危险品运输编号:
    1759
  • 危险性描述:
    H302,H315,H318,H335
  • 储存条件:
    -20°C,惰性气体

SDS

SDS:73c26e39a449564a99678cf7d88f70f2
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Amino Lactonization and Amino Oxygenation of Alkenes Using <i>O</i>-Benzoylhydroxylamines
    作者:Brett N. Hemric、Kun Shen、Qiu Wang
    DOI:10.1021/jacs.6b02840
    日期:2016.5.11
    A copper-catalyzed amino lactonization of unsaturated carboxylic acids has been achieved as well as the analogous intermolecular three-component amino oxygenation of olefins. The transformation features mild conditions and a remarkably broad substrate scope, offering a novel and efficient approach to construct a wide range of amino lactones as well as 1,2-amino alcohol derivatives. Mechanistic studies
    已经实现了铜催化的不饱和羧酸的氨基内酯化以及烯烃的类似分子间三组分氨基氧化。该转化具有温和的条件和非常广泛的底物范围,为构建各种氨基内酯和 1,2-氨基醇衍生物提供了一种新颖而有效的方法。机理研究表明,该反应是通过独特的 O-苯甲酰羟胺促进的烯烃亲电胺化进行的。
  • [EN] INTERMEDIATES USEFUL FOR THE SYNTHESIS OF PYRROLOBENZODIAZEPINES<br/>[FR] INTERMÉDIAIRES UTILES POUR LA SYNTHÈSE DE PYRROLOBENZODIAZÉPINES
    申请人:SPIROGEN LTD
    公开号:WO2011128650A1
    公开(公告)日:2011-10-20
    A compound of formula (I): which is substantially free of any of the corresponding compound of formula (IB): methods of making such compounds, and the further transformation of such compounds.
    具有式(I)的化合物:基本上不含有式(IB)对应的任何化合物;制备这种化合物的方法,以及这种化合物的进一步转化。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或硫原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • [EN] PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORGAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES<br/>[FR] COMPOSÉS PYRROLOSULFONAMIDES POUR LA MODULATION DE L'ACTIVITÉ DU RÉCEPTEUR ORPHELIN GAMMA APPARENTÉ AU RÉCEPTEUR NUCLÉAIRE ORPHELIN RAR (ROR-GAMMA, NR1F3) ET POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES CHRONIQUES ET AUTO-IMMUNES
    申请人:PHENEX PHARMACEUTICALS AG
    公开号:WO2012139775A1
    公开(公告)日:2012-10-18
    The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administrating these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo sulfonamide compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.
    本发明提供了针对孤儿核受体RORγ的调节剂,以及通过向需要的人类或哺乳动物施用这些新型的RORγ调节剂来治疗RORγ介导的疾病的方法。具体而言,本发明提供了式(1)的吡咯磺酰胺化合物及其对映体、非对映体、互变异构体、溶剂化物和药用可接受的盐。
  • TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    申请人:WAGNER Holger
    公开号:US20120046304A1
    公开(公告)日:2012-02-23
    The present invention relates to compounds defined by formula I wherein the variables R 1 -R 8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol ester transfer protein (CETP) and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme.
    本发明涉及由公式I定义的化合物 其中变量R1-R8定义如说明书中所述,具有宝贵的药理活性。特别是,这些化合物是胆固醇酯转移蛋白(CETP)的抑制剂,因此适合用于治疗和预防可以通过抑制该酶而影响的疾病。
查看更多